难治性重性抑郁障碍的脑深部电刺激:综合综述
本综述总结脑深部电刺激(DBS)治疗难治性重性抑郁障碍(MDD)的最新临床证据与技术进展。Meta分析、开放标签研究和少数对照研究显示DBS对部分患者有效,但随机对照试验结果不一,需解决症状客观追踪、患者选择、靶点与参数优化及机制理解等挑战。
要点
- DBS对部分难治性MDD患者有临床疗效,但随机对照试验结果不一致。
- 需客观追踪MDD症状以敏感特异地评估DBS疗效。
- 需明确最可能获益的患者人群并优化个体化靶点与刺激参数。
核心结论
- DBS是部分难治性MDD患者有前景的治疗,但随机对照试验结果不一,广泛采用前须解决多项挑战。
研究设计与样本
- 综述类文章,汇总Meta分析、开放标签研究及少数对照研究等临床证据。
主要发现
- Meta分析、开放标签研究和少数对照研究已显示DBS对MDD的临床有效性。
- 随机对照试验结果不一,凸显广泛采用DBS前须解决的挑战。
临床怎么用
- 临床应认识到DBS对难治性MDD的疗效证据存在异质性,暂不宜广泛采用。
- 实践需关注客观症状追踪、患者选择、个体化靶点与刺激参数优化及机制理解。
局限性
- 随机对照试验结果不一,DBS对MDD的疗效尚不确定。
- 症状评估的敏感性与特异性、最优患者人群、靶点与参数选择及机制均未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deep brain stimulation (DBS) has emerged as a promising treatment for select patients with refractory major depressive disorder (MDD). The clinical effectiveness of DBS for MDD has been demonstrated in meta-analyses, open-label studies, and a few controlled studies. However, randomized controlled trials have yielded mixed outcomes, highlighting challenges that must be addressed prior to widespread adoption of DBS for MDD. These challenges include tracking MDD symptoms objectively to evaluate the clinical effectiveness of DBS with sensitivity and specificity, identifying the patient population that is most likely to benefit from DBS, selecting the optimal patient-specific surgical target and stimulation parameters, and understanding the mechanisms underpinning the therapeutic benefits of DBS in the context of MDD pathophysiology. In this review, we provide an overview of the latest clinical evidence of MDD DBS effectiveness and the recent technological advancements that could transform our understanding of MDD pathophysiology, improve the clinical outcomes for MDD DBS, and establish a path forward to develop more effective neuromodulation therapies to alleviate depressive symptoms.
引用
- Johnson KA, Okun MS, Scangos KW, et al. Deep brain stimulation for refractory major depressive disorder: a comprehensive review. Mol Psychiatry. 2024. PMID: 38287101. doi:10.1038/s41380-023-02394-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。